• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nagashima 型掌跖角化病:临床特征、遗传特征及临床管理。

Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management.

机构信息

Department of Orthopaedics, West China Hospital of Sichuan University, No. 37 Guoxue Alley, Wuhou District, Chengdu, 610041 Sichuan, China.

Department of Dermatology, Shanghai Ninth Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, China.

出版信息

Biomed Res Int. 2021 Jan 27;2021:8841994. doi: 10.1155/2021/8841994. eCollection 2021.

DOI:10.1155/2021/8841994
PMID:33575348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7861918/
Abstract

Nagashima-type palmoplantar keratosis (NPPK) is the most prevalent palmoplantar keratoderma (PPK) in East Asia. Homozygous or compound heterozygous loss-of-function mutations in serpin peptidase inhibitor, clade B (ovalbumin), and member 70 (SERPINB7), which encodes members of the serine protease inhibitor superfamily, have been identified as the cause of NPPK. Clinical manifestations of NPPK include well-demarcated erythema, mild to moderate hyperkeratosis on the whole palm, and sole with transgrediens, extending to the dorsal surfaces of the hands and feet, inner wrists, ankles, and the Achilles tendon areas. In this study, we perform a review of relevant clinical cases aimed at elucidating the clinical characteristics, genetic characterization, differential diagnoses, and clinical management of NPPK. A better understanding of the clinical characteristics and pathogenic gene characterization of NPPK will enhance the diagnosis of NPPK, identify related diseases, and inform on the precise therapy and prognosis. Moreover, it will promote the awareness of NPPK in non-Asian regions.

摘要

Nagashima 型掌跖角化病(NPPK)是东亚最常见的掌跖角化病(PPK)。丝氨酸蛋白酶抑制剂、B 族(卵清蛋白)和成员 70(SERPINB7)的同源或复合杂合功能丧失突变已被确定为 NPPK 的原因,该基因编码丝氨酸蛋白酶抑制剂超家族的成员。NPPK 的临床表现包括界限清楚的红斑,整个手掌轻度至中度过度角化,足底呈移行性角化,延伸到手和脚的背面、内腕、脚踝和跟腱区域。在这项研究中,我们回顾了相关的临床病例,旨在阐明 NPPK 的临床特征、遗传特征、鉴别诊断和临床管理。更好地了解 NPPK 的临床特征和致病基因特征将有助于 NPPK 的诊断,识别相关疾病,并为精确的治疗和预后提供信息。此外,它将提高非亚洲地区对 NPPK 的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/5abc88fba7b1/BMRI2021-8841994.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/8acb33de78b7/BMRI2021-8841994.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/d03ba1071f2b/BMRI2021-8841994.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/46d2ff494a85/BMRI2021-8841994.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/3880b6f31fe2/BMRI2021-8841994.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/5abc88fba7b1/BMRI2021-8841994.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/8acb33de78b7/BMRI2021-8841994.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/d03ba1071f2b/BMRI2021-8841994.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/46d2ff494a85/BMRI2021-8841994.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/3880b6f31fe2/BMRI2021-8841994.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe9/7861918/5abc88fba7b1/BMRI2021-8841994.005.jpg

相似文献

1
Nagashima-Type Palmoplantar Keratosis: Clinical Characteristics, Genetic Characterization, and Clinical Management.Nagashima 型掌跖角化病:临床特征、遗传特征及临床管理。
Biomed Res Int. 2021 Jan 27;2021:8841994. doi: 10.1155/2021/8841994. eCollection 2021.
2
Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis.丝氨酸蛋白酶抑制剂超家族成员 SERPINB7 的突变导致 Nagashima 型掌跖角化病。
Am J Hum Genet. 2013 Nov 7;93(5):945-56. doi: 10.1016/j.ajhg.2013.09.015. Epub 2013 Oct 24.
3
Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.在中国人群的 Nagashima 型掌跖角化病的 8 个病例中发现了 SERPINB7 的两个新突变。
J Dermatol. 2022 May;49(5):539-544. doi: 10.1111/1346-8138.16310. Epub 2022 Feb 17.
4
Highly prevalent SERPINB7 founder mutation causes pseudodominant inheritance pattern in Nagashima-type palmoplantar keratosis.高度流行的丝氨酸蛋白酶抑制剂 B7 种系突变导致 Nagashima 型掌跖角化病的拟显性遗传模式。
Br J Dermatol. 2014 Oct;171(4):847-53. doi: 10.1111/bjd.13076. Epub 2014 Sep 22.
5
Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency.长岛型掌跖角化病:一种由丝氨酸蛋白酶抑制剂B7缺乏引起的常见亚洲型疾病。
J Invest Dermatol. 2014 Aug;134(8):2076-2079. doi: 10.1038/jid.2014.156.
6
Nagashima-type palmoplantar keratosis in a Chinese Han population.中国汉族人群中的长岛型掌跖角化病。
Mol Med Rep. 2016 Nov;14(5):4049-4054. doi: 10.3892/mmr.2016.5757. Epub 2016 Sep 21.
7
[Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe].[长岛型掌跖角化病:欧洲一种鲜为人知的掌跖角化病]
Ann Dermatol Venereol. 2019 Feb;146(2):125-130. doi: 10.1016/j.annder.2018.11.005. Epub 2018 Dec 21.
8
Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.中国 Nagashima 型掌跖角化病的调查:234 例患者的横断面研究。
J Dermatol. 2023 Mar;50(3):375-382. doi: 10.1111/1346-8138.16621. Epub 2022 Nov 1.
9
Spontaneous clinical remission of Nagashima-type palmoplantar keratoderma in a patient of Korean descent with a heterozygous SERPINB7 mutation.一名韩裔患者携带杂合性 SERPINB7 突变,自发性出现 Nagashima 型掌跖角化过度症的临床缓解。
Pediatr Dermatol. 2024 Mar-Apr;41(2):369-371. doi: 10.1111/pde.15511. Epub 2024 Jan 2.
10
SERPINB7 mutation causes Nagashima-type palmoplantar keratosis and its spatiotemporal expression in zebrafish.丝氨酸蛋白酶抑制剂 B7 突变导致 Nagashima 型掌跖角化病及其在斑马鱼中的时空表达。
Exp Dermatol. 2023 Jun;32(6):766-776. doi: 10.1111/exd.14762. Epub 2023 Feb 20.

引用本文的文献

1
A Case of Palmoplantar Keratodermas Complicated by Pseudoainhum and Literature Review.1例并发假性断肢的掌跖角化病病例及文献复习
Clin Cosmet Investig Dermatol. 2025 Jul 31;18:1827-1831. doi: 10.2147/CCID.S534631. eCollection 2025.

本文引用的文献

1
SERPINB7 novel mutation in Chinese patients with Nagashima-type palmoplantar keratosis and cases associated with atopic dermatitis.中国长岛型掌跖角化病患者及与特应性皮炎相关病例中的丝氨酸蛋白酶抑制剂B7新突变。
Int J Dermatol. 2020 Sep;59(9):e320-e322. doi: 10.1111/ijd.14901. Epub 2020 May 13.
2
Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutation.芬兰由丝氨酸蛋白酶抑制剂B7基因奠基者突变引起的长岛型掌跖角化病。
J Am Acad Dermatol. 2020 Aug;83(2):643-645. doi: 10.1016/j.jaad.2019.11.004. Epub 2019 Nov 7.
3
Progressive Symmetrical Erythrokeratoderma Associated with Punctate Palmoplantarkeratoderma.
进行性对称性红斑角化病伴点状掌跖角化病
Indian Dermatol Online J. 2019 Mar-Apr;10(2):183-186. doi: 10.4103/idoj.IDOJ_105_18.
4
[Nagashima-type palmoplantar keratoderma: A little-known palmoplantar keratoderma in Europe].[长岛型掌跖角化病:欧洲一种鲜为人知的掌跖角化病]
Ann Dermatol Venereol. 2019 Feb;146(2):125-130. doi: 10.1016/j.annder.2018.11.005. Epub 2018 Dec 21.
5
Symmetrical acral keratoderma revisited: proposal for a new term, 'pigmented carpotarsal hyperkeratosis'.对称性肢端角化病再探:提出一个新术语,“色素性掌跖过度角化症”。
J Eur Acad Dermatol Venereol. 2019 Feb;33(2):277-280. doi: 10.1111/jdv.15266. Epub 2018 Oct 23.
6
Nagashima-type palmoplantar keratoderma and malignant melanoma in Japanese patients.日本患者中的长岛型掌跖角化病与恶性黑色素瘤
Br J Dermatol. 2019 Feb;180(2):415-416. doi: 10.1111/bjd.17251. Epub 2018 Nov 4.
7
Coexistence of X-linked ichthyosis and Nagashima-type palmoplantar keratosis: A case report.X连锁鱼鳞病与长岛型掌跖角化病并存:一例报告。
J Dermatol. 2019 Feb;46(2):e54-e55. doi: 10.1111/1346-8138.14537. Epub 2018 Jul 13.
8
A follow-up report of acral melanoma in a patient with Nagashima-type palmoplantar keratosis: validation of SERPINB7 mutation and local recurrence.一名患有长岛型掌跖角化病患者的肢端黑色素瘤随访报告:SERPINB7 突变验证与局部复发
Eur J Dermatol. 2018 Aug 1;28(4):519-520. doi: 10.1684/ejd.2018.3317.
9
A novel frameshift SERPINB7 mutation in a Chinese case with Nagashima-type palmoplantar keratosis: case report and review of the literature.
Clin Exp Dermatol. 2018 Dec;43(8):953-955. doi: 10.1111/ced.13682. Epub 2018 Jun 11.
10
Topical Gentamicin for the Treatment of Genetic Skin Diseases.局部使用庆大霉素治疗遗传性皮肤疾病。
J Invest Dermatol. 2018 Apr;138(4):731-734. doi: 10.1016/j.jid.2017.12.008.